Routine bioimpedance-derived volume assessment for all hypertensives: a new paradigm

Area of Science:

• Cardiology
• Nephrology
• Public Health

Background:

• Hypertension is a prevalent global disease associated with significant morbidity, mortality, and healthcare costs.
• Subclinical fluid overload is a key, often undetected, contributor to hypertension.
• Current clinical methods for assessing hydration are unreliable.

Discussion:

• Bioimpedance analysis offers a noninvasive, accurate, and reproducible method for detecting subclinical fluid accumulation.
• Studies, including a meta-analysis in resistant hypertension, show improved blood pressure control with bioimpedance-guided treatment compared to clinical judgment alone.
• Optimizing fluid status is linked to better blood pressure management, reduced left ventricular mass, decreased arterial stiffness, and improved survival.

Key Insights:

• Clinical assessment of hydration is insufficient for managing hypertension.
• Bioimpedance analysis is a valuable tool for identifying fluid overload in hypertensive individuals.
• Targeted fluid management guided by bioimpedance can enhance antihypertensive treatment efficacy.

Outlook:

• A combined approach using bioimpedance and traditional methods may optimize individualized antihypertensive strategies.
• Further research could validate the long-term benefits of bioimpedance-guided fluid management on end-organ damage.
• Integrating bioimpedance into routine hypertension care could represent a significant public health advancement.